|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT01952392 |
|
Date of registration:
|
21/08/2013 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
AReMIS |
|
Scientific title:
|
Study on the Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome |
|
Date of first enrolment:
|
October 2013 |
|
Target sample size:
|
4992 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01952392 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Patients aged 18 years or more, both genders, with an acute coronary syndrome (ACS), agreed
to participate and able to respond to an interview in French and/or providing the details
of an alternative replier (proxy) if necessary.
No Exclusion Criteria.
Age minimum:
18 Years
Age maximum:
130 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Acute Coronary Syndrome
|
|
Primary Outcome(s)
|
|
Drug exposure
[Time Frame: Recent]
|
|
Medical information
[Time Frame: At baseline visit]
|
|
Drug exposure
[Time Frame: Current]
|
|
Drug exposure
[Time Frame: Past]
|
|
Secondary Outcome(s)
|
|
Other medical events of interest
[Time Frame: During follow-up (up to 12 months)]
|
|
Secondary ID(s)
|
|
NIS-CFR-BRI-2012/1
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|